119 related articles for article (PubMed ID: 35101281)
1. Does the public know when a scientific controversy is over? Public perceptions of hydroxychloroquine in France between April 2020 and June 2021.
Schultz É; Atlani-Duault L; Peretti-Watel P; Ward JK
Therapie; 2022; 77(5):591-602. PubMed ID: 35101281
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
[TBL] [Abstract][Full Text] [Related]
3. Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.
Gasmi A; Peana M; Noor S; Lysiuk R; Menzel A; Gasmi Benahmed A; Bjørklund G
Appl Microbiol Biotechnol; 2021 Feb; 105(4):1333-1343. PubMed ID: 33515285
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
Shah S; Das S; Jain A; Misra DP; Negi VS
Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213
[TBL] [Abstract][Full Text] [Related]
5. Exploring insights of hydroxychloroquine, a controversial drug in Covid-19: An update.
Joshi G; Thakur S; Mayank ; Poduri R
Food Chem Toxicol; 2021 May; 151():112106. PubMed ID: 33722600
[TBL] [Abstract][Full Text] [Related]
6. Effects of chloroquine or hydroxychloroquine treatment on non-SARS-CoV2 viral infections: A systematic review of clinical studies.
Cui X; Sun J; Minkove SJ; Li Y; Cooper D; Couse Z; Eichacker PQ; Torabi-Parizi P
Rev Med Virol; 2021 Nov; 31(6):e2228. PubMed ID: 33694220
[TBL] [Abstract][Full Text] [Related]
7. Outside any therapeutic trial prescription of hydroxychloroquine for hospitalized patients with covid-19 during the first wave of the pandemic: A national inquiry of prescription patterns among French hospitalists.
Bosquet A; Affo C; Plaisance L; Poenou G; Mortier E; Mahé I
PLoS One; 2022; 17(1):e0261843. PubMed ID: 35061735
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine Controversies: Clinical Trials, Epistemology, and the Democratization of Science.
Berlivet L; Löwy I
Med Anthropol Q; 2020 Dec; 34(4):525-541. PubMed ID: 33210338
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery.
Chen Y; Li MX; Lu GD; Shen HM; Zhou J
Int J Biol Sci; 2021; 17(6):1538-1546. PubMed ID: 33907517
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine and COVID-19: Lack of Efficacy and the Social Construction of Plausibility.
Rughiniş C; Dima L; Vasile S
Am J Ther; 2020; 27(6):e573-e583. PubMed ID: 33136577
[TBL] [Abstract][Full Text] [Related]
11. What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology.
Altulea D; Maassen S; Baranov MV; van den Bogaart G
J Mol Cell Biol; 2021 Jul; 13(3):175-184. PubMed ID: 33693723
[TBL] [Abstract][Full Text] [Related]
12. The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19.
Lee Z; Rayner CR; Forrest JI; Nachega JB; Senchaudhuri E; Mills EJ
Am J Trop Med Hyg; 2021 Jan; 104(1):35-38. PubMed ID: 33236703
[TBL] [Abstract][Full Text] [Related]
13. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review.
Rodrigo C; Fernando SD; Rajapakse S
Clin Microbiol Infect; 2020 Aug; 26(8):979-987. PubMed ID: 32470568
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19.
Meo SA; Klonoff DC; Akram J
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4539-4547. PubMed ID: 32373993
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
16. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
[TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection.
Infante M; Ricordi C; Alejandro R; Caprio M; Fabbri A
Expert Rev Anti Infect Ther; 2021 Jan; 19(1):5-16. PubMed ID: 32693652
[TBL] [Abstract][Full Text] [Related]
18. Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID-19: A simulation study.
Okada JI; Yoshinaga T; Washio T; Sawada K; Sugiura S; Hisada T
Clin Transl Sci; 2021 May; 14(3):1092-1100. PubMed ID: 33404133
[TBL] [Abstract][Full Text] [Related]
19. Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals.
Mallhi TH; Ahmad A; Butt MH; Misbah S; Khan YH; Alotaibi NH
J Coll Physicians Surg Pak; 2020 Oct; 30(10):124-128. PubMed ID: 33115586
[TBL] [Abstract][Full Text] [Related]
20. Unfavorable hydroxychloroquine COVID-19 research associated with authors having a history of political party donations.
Berry AC; Gonnering RS; Rodriguez I; Zhang Q; Berry BB
Rev Cardiovasc Med; 2021 Mar; 22(1):191-198. PubMed ID: 33792262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
